East Windsor, N.J. – Aurobindo Pharma Limited has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application Metronidazole Vaginal Gel, 0.75%. Aurobindo Pharma’s Metronidazole Vaginal Gel, are an AB-rated generic equivalent to the reference listed drug (RLD), MetroGel® Vaginal Gel, manufactured by Bausch Health US, LLC.

Metronidazole Vaginal Gel are indicated in the:

• Treatment of bacterial vaginosis (formerly referred to as Haemophilus vaginitis, Gardnerella vaginitis, nonspecific vaginitis, Corynebacterium vaginitis, or anaerobic vaginosis).